NCT06160219View on ClinicalTrials.gov

Prophylactic Use of Hydroxycobolamin in Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 28, 2019

Primary Completion Date

November 20, 2023

Study Completion Date

November 27, 2023

Conditions
Vasoplegic Syndrome
Interventions
DRUG

Hydroxycobalamin

prophylactic use of hydroxycobalamin in vasoplegia in high risk patients undergoing cardiac surgeries

Trial Locations (1)

Unknown

AinShams university hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06160219 - Prophylactic Use of Hydroxycobolamin in Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass | Biotech Hunter | Biotech Hunter